Integrated science in cannabis with R. Michael Smullen. Smullen is Co-Founder, CEO, and Chairman, for AltMed Enterprises. AME is a nationally recognized medical cannabis company with operations in Arizona and Florida. Michael spent 31 years in the pharmaceutical and biotech industries building and leading commercial operations for several companies including three start-ups. Before founding AltMed Enterprises in 2014, Michael, a Senior Executive at MedImmune, was responsible for building a world class commercial organization and successfully launching the first monoclonal antibody approved in the US for an infectious disease. The drug, Synagis, became the 9th most successful biotech product of all time.
